Caprice Resources Ltd (ASX:CRS) Suspends Trading
Caprice Resources Ltd (ASX:CRS) announces a temporary trading pause pending further updates.
Tag: Regulatory News & Compliance
Yowie Group Ltd (ASX:YOW) Calls in Keybridge Capital Loan Facility
Yowie Group Ltd (ASX:YOW) calls in its loan facility with Keybridge Capital Limited and explores new capital solutions.
LCL Resources Limited (ASX:LCL) Pauses Trading
LCL Resources Limited (ASX:LCL) temporarily pauses trading of its securities pending a further announcement.
Winsome Resources (ASX:WR1) Secures Funding for Trans-Atikh Project
Winsome Resources (ASX:WR1) secures conditional Stage 1 funding for the Trans-Atikh Project, advancing lithium infrastructure in Québec.
8VI Holdings Limited (ASX:8VI) Suspends Quotation on ASX
8VI Holdings Limited (ASX:8VI) requests suspension from ASX trading effective 10 February 2025, leading to delisting.
Arovella Therapeutics Limited (ASX:ALA) Suspends Quotation Pending Capital Raise
Arovella Therapeutics Limited (ASX:ALA) suspends ASX trading pending a capital raising announcement.
Keybridge Capital Limited (ASX:KBC) Appoints Voluntary Administrator
Keybridge Capital Limited (ASX:KBC) appoints a voluntary administrator amid legal and financial challenges impacting its operations.
CLINUVEL Pharmaceuticals Limited (ASX:CUV) Reports Preliminary CUV052 Study Results
CLINUVEL (ASX:CUV) releases preliminary results from the CUV052 study, supporting SCENESSE®’s safety in adolescent EPP patients.
Terramin Australia Ltd (ASX:TZN) Updates on Bird in Hand Gold Project Appeal
Terramin Australia (ASX:TZN) updates on the legal appeal and operational progress of its Bird in Hand Gold Project, highlighting significant economic benefits for South Australia.
PYC Therapeutics (ASX:PYC) Receives Approval to Begin Human Trials for PKD Treatment
PYC Therapeutics (ASX:PYC) receives regulatory approval to commence human trials for its PKD drug candidate, PYC-003.